Final FDA rule on device, drug and biologic combos is available

01/23/2013 | MassDevice.com (Boston)

A final rule released this week by the FDA outlines current good manufacturing practice standards for products that combine drugs, medical devices and biologics. The rule aims to clarify the CGMP criteria for new and existing combination products that are sold together or are "single-entity" combinations.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ